Skip to Content

'
Abenaa M. Brewster, M.D., M.H.S.

Present Title & Affiliation

Primary Appointment

Associate Professor (Tenured), Department of Clinical Cancer Prevention, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX
Attending Physician, Department of Breast Medical Oncology, Division of Cancer Medicine, Breast Medical Oncology Clinic, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Associate Professor (Tenured), Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX

Bio Statement

Dr. Abenaa Brewster received her BS from Stanford University, M.D. degree from Harvard Medical School and a Master of Health Science degree in Epidemiology at the Johns Hopkins School of Public Health. She is an Associate Professor in the Department of Clinical Cancer Prevention at MD Anderson Cancer Center and has an adjunct appointment in the Department of Epidemiology.  Her clinical interest is breast cancer and she is a medical oncologist in the Nellie B. Connally Breast Center.  Dr. Brewster has expertise using methods of molecular epidemiology to investigate epidemiological and biological factors that determine risk for breast cancer and survival. She is particularly interested in understanding how ethnicity and obesity influence a woman’s risk and survival after a diagnosis of breast cancer.  She has received funding from the American Society of Clinical Oncology, the National Institute of Health and the Susan G. Komen Foundation.  She enjoys teaching and has served as a facilitator for the UT Evidence Based Workshop and a lecturer at the UT School of Public Health.

Office Address

The University of Texas MD Anderson Cancer Center
P. O. Box 301439
Department of Clinical Cancer Prevention
Unit Number: 1360
Houston, TX 77230-1439
Room Number: CPB6.3528
Phone: (713) 745-4928
Fax: (713) 563-5746
Email: abrewster@mdanderson.org

Education & Training

Degree-Granting Education

2001 Johns Hopkins School of Hygiene & Public Health, Baltimore, MD, Master of Health Science, Cancer Epidemiology
1995 Harvard Medical School, Boston, MA, MD, Medicine
1990 Stanford University, Stanford, CA, BS, Chemistry

Board Certifications

1/2012 Medical Oncology, American Board of Internal Medicine

Experience/Service

Academic Appointments

Assistant Professor, Department of Clinical Cancer Prevention, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 4/2002-8/2009
Assistant Professor, Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 4/2002-8/2009

Administrative Appointments/Responsibilities

Faculty Senate Representative, Department of Clinical Cancer Prevention, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2006-9/2012

Institutional Committee Activities

Member, Clinical Research Advisory Committee, 9/2012-present
Member, Clinical Research Committee, 9/2012-present
Member, Advisory Board Center for Community-Engaged Translational Research Steering Committee, 2012-present
Member, Duncan Fund Institute Clinical Cancer Prevention Research Core Steering Committee, 2011-present
Member, Clinical Revenue Cycle Committee, 2011-present
Member, Health Services Research Chair Search Committee, The University of Texas MD Anderson Cancer Center, 9/2010-8/2011
Member, Breast Tissue Oversight Committee, 2009-present
Member, Advisory Committee for the Patient-reported Outcomes, Survey & Population Research (PROSPR) Shared Resource, The University of Texas MD Anderson Cancer Center, 2009-present
Member, Faculty Welfare Committee, 2009-2012
Member, Clinical Effectiveness Subcommittee, The University of Texas MD Anderson Cancer Center, 9/2007-8/2011
Member, Cancer Prevention Center Scientific Committee, The University of Texas MD Anderson Cancer Center, 6/2006-2011
Member, Infection Control Committee, The University of Texas MD Anderson Cancer Center, 5/2006-9/2012

Honors and Awards

2010 Seminar Attendee, Association of American Medical College's (AAMC) Mid Career Women's Faculty Development
2008 Seminar Attendee, Association of American Medical College's (AAMC) Early Career Women's Faculty Development
2003-2007 Clinical Research Loan Repayment Program, National Institutes of Health
2003 Young Investigator Award, American Society of Clinical Oncology
2001 Honorable Mention (2nd place) for Clinical Research, Johns Hopkins Cancer Center Fellows Research Day
1994 Slack Award for Student Medical Research, National Medical Association
1993-1994 Karen Grunebaum Oncology Fellowship, Karen Grunebaum Foundation
1993 Second Place Award for Student Abstracts, American Gastroenterology Association
1990-1995 STARR Foundation Graduate Academic Scholarship, STARR Foundation
1986-1990 STARR Foundation Undergraduate Academic Scholarship, STARR Foundation
1986-1988 Dean's List, Rutgers University

Professional Memberships

American Association for Cancer Research
Distinguished Lectureship on the Science of Cancer Health Disparities Award Selection Committee, 8/2012-4/2013
Member, Women in Cancer Research, 11/2011-present
Member, Scientific Review Committee, 7/2010-present
Active Member, 2000-present
American Society of Clinical Oncology
Member, Cancer Education Committee on Cancer Prevention/Epidemiology, 6/2010-5/2012
Member, Scientific Committee, 2007-present
Associate Member, 1999-present
Dr. Susan Love Research Foundation
Dr. Susan Love Research Foundation’s Army of Women Scientific Advisory Committee, 9/2010-present
Meharry/Vanderbilt/TSU Cancer Partnership Program Steering Committee, Nashville, TN
Member, 2012-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Martínez ME, Pond E, Wertheim BC, Nodora JN, Jacobs ET, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Komenaka IK, Thompson P. Association Between Parity and Obesity in Mexican and Mexican-American Women: Findings from the Ella Binational Breast Cancer Study. J Immigr Minor Health 15:234-243, 4/2013. e-Pub 5/2012. PMCID: PMC3469728.
2. Murray JL, Thompson P, Yoo SY, Do KA, Zhou R, Liu Y, Sahin AA, Bondy ML, Brewster AM. Prognostic Value of Single Nucleotide Polymorphisms of Candidate Genes Associated with Inflammation in Early Stage Breast Cancer. Breast Cancer Research and Treatment, 3/2013. PMID: 23529385.
3. Bidstrup PE, Dalton SO, Christensen, J, Tjonneland A, Benzon Larsen S, Randi Karlsen, Brewster A, Bondy M , Johansen C. Changes in body mass index and alcohol and tobacco consumption among breast cancer survivors and cancer-free women: a prospective study in the Danish Diet, Cancer and Health Cohort. Acta Oncologica 52(2):327-35, 2/2013. PMID: 23244678.
4. Brewster AM, Bedrosian I, Parker PA, Dong W, Peterson SK, Cantor SB, Crosby M, Shen Y. Association between contralateral prophylactic mastectomy and breast cancer outcomes by hormone receptor status. Cancer 118(22):5637-43, 11/2012. e-Pub 4/2012. PMCID: PMC3478501.
5. Mala Pande, Patricia A. Thompson, Kim-Anh Do, Aysegul A. Sahin, Christopher I. Amos, Marsha L. Frazier, Melissa L. Bondy and Abenaa M. Brewster. Genetic variants in the vitamin D pathway and breast cancer disease-free survival. Carcinogenesis, 11/2012.
6. Cruz GI, Martínez ME, Natarajan L, Wertheim BC, Gago-Dominguez M, Bondy M, Daneri-Navarro A, Meza-Montenegro MM, Gutierrez-Millan LE, Brewster A, Schedin P, Komenaka IK, Castelao JE, Carracedo A, Redondo CM, Thompson PA. Hypothesized role of pregnancy hormones on HER2+ breast tumor development. Breast Cancer Res Treat. e-Pub 11/2012. PMID: 23135573.
7. Bailes AA, Kuerer HM, Lari SA, Jones LA, Brewster AM. Impact of Race and Ethnicity on Features and Outcome of Ductal Carcinoma in Situ of the Breast. Cancer. e-Pub 6/2012. PMCID: PMC3461121.
8. Moulder S, Gladish G, Ensor J, Gonzalez-Angulo AM, Cristofanilli M, Murray JL, Booser D, Giordano SH, Brewster A, Moore J, Rivera E, Hortobagyi GN, Tran HT. A phase 1 study of weekly everolimus (RAD001) in combination with docetaxel in patients with metastatic breast cancer. Cancer 118(9):2378-84, 5/2012. e-Pub 10/2011. PMID: 22006179.
9. Dominici LS, Mittendorf EA, Wang X, Liu J, Kuerer HM, Hunt KK, Brewster A, Babiera GV, Buchholz TA, Meric-Bernstam F, Bedrosian I. Implications of constructed biologic subtype and its relationship to locoregional recurrence following mastectomy. Breast Cancer Res. 14(3), 5/2012. e-Pub 5/2012. PMCID: PMC3446345.
10. Wang LE, Han CH, Xiong P, Bondy ML, Yu TK, Brewster AM, Shete S, Arun BK, Buchholz TA, Wei Q. Gamma-ray-induced mutagen sensitivity and risk of sporadic breast cancer in young women: a case-control study. Breast Cancer Res Treat 132(3):1147-55, 4/2012. e-Pub 1/2012. PMID: 22218884.
11. Kuerer HM, Lari SA, Arun BK, Hu CY, Brewster A, Mittendorf EA, Albarracin CT, Babiera GV, Caudle AS, Wagner JL, Litton JK, Bedrosian I, Meric-Bernstam F, Lucci A, Hunt KK. Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass. Breast Cancer Res Treat 132. e-Pub 3/2012. PMID: 22392043.
12. Kelly CM, Green MC, Broglio K, Thomas ES, Brewster AM, Valero V, Ibrahim NK, Gonzalez-Angulo AM, Booser DJ, Walters RS, Hunt KK, Hortobagyi GN, Buzdar AU. Phase III Trial Evaluating Weekly Paclitaxel versus Docetaxel in Combination with Capecitabine in Operable Breast Cancer. J Clin Oncol 30(9):930-5, 3/2012. e-Pub 2/2012. PMID: 22331946.
13. Arun BK, Valero V, Liu D, Brewster AM, Green M, Gutierrez-Barrera AM, Akar U, Rivera E, Esteva FJ, Buzdar AU, Hortobagyi GN, Sneige N. Short -term biomarker modulation prevention study of Anastrozole in Women at increased risk for second primary breast cancer. Cancer Prev Res (Phila) 5(2):276-82, 2/2012. e-Pub 11/2011. PMID: 22102688.
14. Del Fabbro E, Parsons H, Warneke CL, Pulivarthi K, Litton JK, Dev R, Palla SL, Brewster A, Bruera E. The Relationship Between Body Composition and Response to Neoadjuvant Chemotherapy in Women with Operable Breast Cancer. Oncologist 17(10):1240-5, 2012. e-Pub 8/2012. PMID: 22903527.
15. Sexton KR, Franzini L, Day RS, Brewster A, Vernon SW, Bondy ML. A review of body size and breast cancer risk in Hispanic and African American women. Cancer 117(23):5271-81, 12/2011. e-Pub 5/2011. PMID: 21598244.
16. Brewster AM, Etzel C, Zhou R, Wong Y, Edge S, Blayney DW, Wilson J, Hudis C, Ottesen R, Hughes ME, Weeks JC, Theriault RL. The impact of obesity on receipt of adjuvant chemotherapy for breast cancer in the National Comprehensive Cancer Network (NCCN) centers. Breast Cancer Res Treat 130(3):897-904, 12/2011. e-Pub 8/2011. PMID: 21809116.
17. Brewster AM, Thompson P, Sahin AA, Do KA, Edgerton ME, Murray JL, Tsavachidis S, Zhou R, Zhang L, Liu Y, Mills GB, Bondy ML. Copy Number Imbalances Between Screen and Symptom-Detected Breast Cancers and Impact on Disease-free Survival. Cancer Prev Res (Phila) 4(10):1609-16, 10/2011. PMCID: PMCPMC3188338.
18. Rachel Zenuk Garcia, Scott C. Carvajal, Anna V. Wilkinson, Patricia A. Thompson, Jesse N. Nodora, Ian K. Komenaka, Abenaa Brewster, Giovanna I. Cruz, Betsy C. Wertheim, Melissa L. Bondy, Marıa Elena Martınez. Factors that influence mammography use and breast cancer. Cancer Causes Control, 10/2011. PMID: 22080276.
19. Thompson PA, Brewster AM, Do K, Baladandayuthapani V, Broom BM, Edgerton M, Hahn K, Murray JL, Sahin A, Tsavachidis S, Wang Y, Zhang L, Hortobagyi GN, Mills GB, Bondy M. Selective genomic copy number imbalances and probability of recurrence in early-stage breast cancer. PLos ONE. PLoS One 6(8), www.plosone.org, 8/2011. e-Pub 8/2011. PMCID: PMC3155554.
20. Zhang G, Brewster A, Guan B, Fan Z, Brown PH, Xu XC. Tumor-suppressor activity of RRIG1 in breast cancer. BMC Cancer 11. e-Pub 1/2011. PMCID: PMC3037341.
21. Brewster AM, Parker PA. Current knowledge on contralateral prophylactic mastectomy among women with sporadic breast cancer. Oncologist 16(7):935-41, 2011. e-Pub 6/2011. PMCID: PMC3228146.
22. Martínez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What can we Learn about Disease Etiology from Case-Case Analyses? Lessons from Breast Cancer. Cancer Epidemiol Biomarkers Prev 19(11):2710-4, 11/2010. e-Pub 9/2010. PMID: 20870734.
23. Brewster AM, Patterson SL, Forman MR, Hughes-Halbert C, Limburg PJ, Ondrey FG, Paskett ED, Wetter DW, Hawk ET. Conference Report: Eighth Annual AACR International Conference on Frontiers in Cancer Prevention Research. Cancer Prev Res (Phila Pa) 3(8):1044-8, 8/2010. e-Pub 7/2010. PMID: 20663980.
24. Han CH, Lu J, Wei Q, Bondy ML, Brewster AM, Yu TK, Buchholz TA, Arun BK, Wang LE. The functional promoter polymorphism (-842G>C) in the PIN1 gene is associated with decreased risk of breast cancer in non-Hispanic white women 55 years and younger. Breast Cancer Res Treat 22(1):243-9, 7/2010. PMCID: PMC2883663.
25. Brown PH, Viner JL, Brewster AM, Heckman CJ, Hurstings S, Johnson K, Mao JT. Conference Report: Seventh Annual AACR International Conference on Frontiers in Cancer Prevention. Cancer Prevention Res 2(11):995-8, 11/2009. PMCID: PMC2830974.
26. Kuerer HM, Albarracin CT, Yang WT, Cardiff RD, Brewster AM, Symmans WF, Hylton NM, Middleton LP, Krishnamurthy S, Perkins GH, Babiera G, Edgerton ME, Czerniecki BJ, Arun BK, Hortobagyi GN. Ductal Carcinoma In Situ: State of the Science and Roadmap to Advance the Field. J Clin Oncol 27(2). e-Pub 12/2008. PMID: 19064970.
27. Moulder SL, Symmans WF, Booser DJ, Madden TL, Lipsanen C, Yuan L, Brewster AM, Cristofanilli M, Hunt KK, Buchholz TA, Zwiebel J, Valero V, Hortobagyi GN, Esteva FJ. Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer. Clin Cancer Res 14(23):7909-16, 12/2008. PMID: 19047121.
28. Litton JK, Gonzalez-Angulo AM, Warneke CL, Buzdar AU, Kau SW, Bondy M, Mahabir S, Hortobagyi GN, Brewster AM. Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancer. J Clin Oncol. 26(25):4072-7, 9/2008. PMID: 18757321.
29. Brewster AM, Hortobagyi G, Broglio K, Kau S, Santa-Maria C, Arun B, Booser D, Valero V, Bondy M, Esteva F. Residual Risk of Breast Recurrence 5 years after adjuvant therapy. J. Natl. Cancer Inst. 100(16):1179-1183, 8/2008. PMID: 18695137.
30. Lu J, Wei Q, Bondy ML, Brewster AM, Bevers TB, Yu TK, Buchholz TA, Meric-Bernstam F, Hunt KK, Singletary SE, Wang LE. Genetic Variants in the H2AFX Promoter Region are Associated with Risk of Sporadic Breast Cancer in Non-Hispanic White Women Aged </= 55 Years. Breast Cancer Res Treat 110(2):357-66, 7/2008. PMCID: PMC3030478.
31. Rivera E, Mejia JA, Arun BK, Adinin RB, Walters RS, Brewster A, Broglio KR, Yin G, Esmaeli B, Hortobagyi GN, Valero V. Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer. Cancer 112(7):1455-61, 4/2008. PMID: 18300256.
32. Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q. Repair Capacity for Ultraviolet Light-Induced DNA Damage Associated with Risk of Non-Melanoma Skin Cancer and Tumor Progression. Clin Cancer Res 13(21):6532-6539, 11/2007. PMID: 17975167.
33. Brewster AM, Do KA, Thompson PA, Hahn KM, Sahin AA, Cao Y, Stewart MM, Murray JL, Hortobagyi GN, Bondy ML. The relationship between epidemiological risk factors and breast cancer recurrence. J Clin Oncol 25(28):4438-4444, 10/2007. PMID: 17785707.
34. Arun B, Valero V, Logan C, Broglio K, Rivera E, Brewster A, Yin G, Green M, Kuerer H, Gong Y, Browne D, Hortobagyi GN, Sneige N. Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res 13(16):4943-8, 8/2007. PMID: 17699874.
35. Brewster AM, Lee JJ, Clayman GL, Clifford JL, Reyes MJ, Zhou X, Sabichi AL, Strom SS, Collins R, Meyers CA, Lippman SM. Randomized trial of adjuvant 13-cis-retinoic acid and interferon alfa for patients with aggressive skin squamous cell carcinoma. Editorial J Clin Oncol., 25:15(15):1974-8, 5/2007. PMID: 17513803.
36. Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluation. Cancer Epidemiol Biomarkers Prev 16(5):950-5, 5/2007. PMID: 17507621.
37. Johnson CM, Ensor J, Broglio K, Smolenski D, Ravdin P, Amos C, Meric-Bernstam F, Brewster A, Bevers T, Arun B, Berry D. Building a predictive breast cancer risk model. AMIA Annu Symp Proc:995, 2007. PMID: 18694095.
38. Lu J, Wei Q, Bondy ML, Li D, Brewster A, Shete S, Yu TK, Sahin A, Meric-Bernstam F, Hunt KK, Singletary SE, Ross MI, Wang LE. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <or=55 years. Carcinogenesis 27(11):2209-16, 11/2006. PMID: 16714331.
39. Lu J, Wei Q, Bondy ML, Yu TK, Li D, Brewster A, Shete S, Sahin A, Meric-Bernstam F, Wang LE. Promoter polymorphism (-786t>C) in the endothelial nitric oxide synthase gene is associated with risk of sporadic breast cancer in non-Hispanic white women age younger than 55 years. Cancer 107(9):2245-53, 11/2006. PMID: 17063466.
40. Brewster AM, Jorgensen TJ, Ruczinski I, Huang HY, Hoffman S, Thuita L, Newschaffer C, Lunn RM, Bell D, Helzlsouer KJ. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer. Breast Cancer Res Treat 95(1):73-80, 2006. PMID: 16319991.
41. Brewster AM, Christo DK, Lai H, Helzlsouer K. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits. Cancer 103(6):1147-53, 3/2005. PMID: 15674856.
42. Shi Q, Wang LE, Bondy ML, Brewster A, Singletary SE, Wei Q. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 25(9):1695-700, 9/2004. PMID: 15090466.
43. Brewster AM, Alberg AJ, Strickland PT, Hoffman SC, Helzlsouer K. XPD polymorphism and risk of subsequent cancer in individuals with nonmelanoma skin cancer. Cancer Epidemiol Biomarkers Prev 13(8):1271-5, 8/2004. PMID: 15298945.
44. Brewster A, Helzlsouer K. Breast cancer epidemiology, prevention, and early detection. Curr Opin Oncol 13(6):420-5, 11/2001. PMID: 11673680.
45. Brewster A. A student's view of a medical teaching exercise. N Engl J Med 329(26):1971-2, 12/1993. PMID: 8247071.

Abstracts
1. Murray JL, Thompson P, Tuna M, Brewster AM, Do K, Edgerton ME, Sahin A, Mills GB, Tsachavdis S, Bondy M. Association of gene copy number alterations in formalin-fixed, paraffin-embedded tumors with prognostic molecular and pathologic tumor subtypes in early-stage breast cancer. ASCO Meeting Abstracts (#572), 2010.
2. Bambhroliya A, Bondy M, Thompson P, Sahin A, Murray JL, Zhou R, Sexton K, Brewster AM. Epidemiologic risk factors associated with breast cancer subtypes. ASCO Meetiing Abstracts (#1585), 2010.
3. Brewster AM, Thompson P, Do KA, Sahin a, Zhang L, Murray JL, Tsachavidis S, Mills GB, Bondy M. Investigation of ethnic differences in the prevalence of chromosomal number aberrations of luminal and triple-negative breast cancers associated with risk of recurrence. ASCO Meeting Abstracts (#51375), 2010.
4. Bayraktar, S, Thompson,PA, Yoo, SY, Do, K, Sahin, AA, Arun, BK, Bondy, ML, Brewster, AM. Prognostic Relevance of Eight Genome Wide Association Studies-identified Single-nucleotide Polymorphisms in Primary Breast Cancer. AACR Frontiers of Cancer Prevention Meeting, 2011.
5. Murray, JL, Thompson, P, Zhou, R, Yoo, SY, Liu, Y, Do, K, Sahin, A, Bondy, M, Brewster. AM. Prognostic value of single nucleotide polymorphisms (SNPs) of candidate genes associated with inflammation in early stage breast cancer. ASCO Meeting, 2011.
6. Brewster, AM, Parker, P, Bedrosian, I, Dong, W, Peterson, S, Cantor, S, Crosby, M, Shen, Y. The Association Between Contralateral Prophylactic Mastectomy and Breast Cancer Survival Outcomes. ASCO Meeting, 2011.

Grant & Contract Support

Title: Risk prediction for ER negative breast cancer recurrence
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 9/1/2012 - 8/31/2018
 
Title: DNA damage in the normal mammary gland: an early molecular marker of breast cancer risk.
Funding Source: AVON Foundation
Role: Co-Principal Investigator
Principal Investigator: Bedrosian, Brewster
Duration: 1/1/2012 - 3/31/2013
 
Title: A Decision Making Framework for Contralateral Prophylatic Mastectomy
Funding Source: NIH/OWCR
Role: Co-Principal Investigator
Principal Investigator: Brewster, Parker
Duration: 9/15/2010 - 8/31/2012
 
Title: DNA Damage as a Biomarker of Risk of Breast Cancer
Funding Source: Susan G. Komen Breast Cancer Foundation
Role: Co-Investigator
Principal Investigator: Isabelle Bedrosian
Duration: 8/3/2009 - 5/2/2013
 
Title: Ethnic differences in the mutational status of the PI3K pathway and breast cancer outcome
Funding Source: Susan G. Komen Breast Cancer Foundation, Disparities Career Catalyst award
Role: Principal Investigator
Duration: 8/3/2009 - 5/2/2013
 
Title: Activation of the AKT and mammalian target of rapamycin (mTor) signaling pathway in breast cancer by serum levels of C-peptide and insulin growth factor-1
Funding Source: Institutional Research Grant
Role: Principal Investigator
Duration: 4/1/2008 - 3/31/2010
 
Title: Comparative Study of Breast Cancers and Their Risk Factors Among Mexican Women in Mexico and the U.S
Funding Source: NCI
Role: Co-Investigator
Principal Investigator: Melissa Bondy
Duration: 8/1/2007 - 9/1/2010
 
Title: Insulin Resistance and Breast Cancer Outcome
Funding Source: NCI
Role: Principal Investigator
Duration: 5/1/2006 - 6/30/2009
 
Title: Breast Cancer Risk Assessment and Genetic Polymorphisms
Funding Source: Intergenetics Incorporation
Role: Principal Investigator
Duration: 7/1/2005 - 9/30/2006
 
Title: DNA Repair and Breast Cancer Susceptibility
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Wang, Li-E
Duration: 8/1/2004 - 4/30/2007
 
Title: Gamma-ray induced mutagen sensitivity in breast cancer
Funding Source: NIH/NCI
Role: Co-Investigator
Principal Investigator: Li-E Wang
Duration: 8/1/2004 - 7/31/2006
 
Title: Modulation of Oxidative Stress as a Breast Cancer Biomarker in African American Women: Role of Low Fat Diet and Weight Loss
Funding Source: American Society of Clinical Oncology, Young Investigator Award
Role: Principal Investigator
Duration: 7/2003 - 1/2006
 
Title: Clinical Research Loan Repayment Program
Funding Source: NIH/NCI
Role: Principal Investigator
Duration: 6/1/2003 - 5/31/2005
 
Title: Start-Up Funds
Funding Source: The University of Texas M. D. Anderson Cancer Center
Role: Principal Investigator
Duration: 3/1/2002 - 8/31/2008

Last updated: 3/27/2013